wellrank.ai
Pharmacy Comp Accreditation Board logo

Pharmacy Comp Accreditation Board

First cited by AI Jun 27, 2026

Surfaced organically in AI answers about compounded glp-1s. Not yet profiled.

Pharmacy Comp Accreditation Board is losing the AEO war.

Not cited in a single tracked AI answer since Jul 1, 2026, down from a peak of 2% visibility in compounded glp-1s on Jun 27, 2026. This page stays public, and recovery shows here the day it happens.

AI Visibility

Visibility trend

Compounded GLP-1s, daily share of AI answers mentioning Pharmacy Comp Accreditation Board, through Jul 6, 2026.

0.0%

Last cited Jul 1, 2026 · peak 2% on Jun 27

By engine

Where Pharmacy Comp Accreditation Board is strong, and where it is invisible.

  • No engine data yet.

Mention sentiment

Tone of AI mentions across all tracked answers.

  • 1 positive mentions
  • 0 neutral
  • 0 mixed or cautious

Recent AI answers mentioning Pharmacy Comp Accreditation Board

PerplexityJun 27, 2026, 12:56 UTC
Is compounded semaglutide safe? How do I avoid sketchy providers?

Compounded semaglutide is not necessarily safe because it is not FDA-approved, meaning the agency does not evaluate its safety, effectiveness, or quality before it is distributed to patients[1][4]. Is It Safe? The safety of compounded semaglutide is uncertain due to several critical risks: Unknown Purity and Potency: Compounded medications may not match the exact specifications of FDA-approved versions, leading to inconsistent dosing or impurities[2]. Dangerous Impurities: Some samples have been found to contain dangerous impurities, risky ingredients, and even banned substances[4]. Incorrect Salt Forms: The FDA has received reports of compounders using semaglutide salts (e.g., sodium or acetate), which differ from the base form in FDA-approved drugs and have not been shown to be safe; some salt forms may not meet federal food, drug, and cosmetic act requirements[5]. Dosing Errors: Patients have mistakenly administered 5 to 20 times their intended dose due to unclear instructions on measuring small volumes with insulin syringes[6]. Adverse Events: The FDA has received 990 adverse event reports associated with compounded semaglutide, including cases requiring hospitalization, and estimates that 10 deaths and 100 hospitalizations may be linked to these drugs[7][9]. Pregnancy Risks: Compounded semaglutide should not be used during pregnancy, as animal studies suggest potential harm to unborn babies[3]. FDA officials and endocrinologists, including Dr. Cecilia Low Wang, recommend against prescribing compounded semaglutide when an FDA-approved product is available[5]. How to Avoid Sketchy Providers To avoid sketchy or unsafe providers, follow these strict guidelines: Require a Prescription: Compounded semaglutide always requires a prescription from a licensed healthcare provider. Steer clear of any pharmacy selling it without one, as you may receive a counterfeit product[1]. Verify Pharmacy Licensing: Only obtain medications through state-licensed pharmacies or outsourcing facilities registered with the FDA[5]. Check for False Advertising: Be cautious of pharmacies or companies advertising compounded semaglutide as "generic" versions of Ozempic or Wegovy. There are no approved generic versions of these drugs[1][5]. Avoid Unverified Claims: Do not trust providers making definitive claims about the safety or effectiveness of compounded semaglutide, as the FDA explicitly states it does not review these for safety[1]. Look for Accreditation: Consult providers who can confirm the credentials of compounding pharmacies, ideally those accredited by organizations like Pharmacy Comp Accreditation Board (PCAB)[2]. Prefer FDA-Approved Options: The most reliable and safe choice is an FDA-approved product (e.g., Wegovy or Ozempic) from the manufacturer [2][4]. If an FDA-approved drug is available to treat your condition, patients should not use a compounded drug[5]. For the safest experience, choose FDA-approved semaglutide from reputable sources like Novo Nordisk (Wegovy) or Eli Lilly (Ozempic) rather than unregulated compounded alternatives.

Mentioned in position 1 of 2

Read full answer with sources →

Competitive Landscape

Pharmacy Comp Accreditation Board vs the brands AI recommends alongside it

The real competitive set in Compounded GLP-1s: brands the engines name in the same answers, ranked on the latest day.

BrandRankAI visibility
Pharmacy Comp Accreditation Board logo
Pharmacy Comp Accreditation BoardThis brand
0.0%
Novo Nordisk logo
Novo Nordisk

1 shared answers

#3
33.3%

Email me when overtakes Pharmacy Comp Accreditation Board

One email the day the ranks flip. Nothing else.

Sources cited around Pharmacy Comp Accreditation Board

The sites engines cite in answers mentioning this brand. Win these, win the answer.

Track Pharmacy Comp Accreditation Board weekly

One email a week: rank moves, new competitors, and the answers that changed. No noise.

Work at Pharmacy Comp Accreditation Board? Get your AI Visibility Audit.

See every buyer intent question your customers ask AI, which ones you are losing, who wins them instead, and the exact sources driving those answers. You will finally understand your buyer intent and what Propel would do to win it.